The term "substance abuse" describes the risky or negative use of psychotropic medications, such as alcohol and illegal narcotics. Substance misuse is when a person uses alcohol, prescription pharmaceuticals, other legal substances, and illegal drugs excessively or improperly. It refers to the potentially harmful use of psychoactive substances that can lead to dependence syndrome, a collection of behavioural, cognitive, and physiological phenomena that typically emerges after repeated substance use and that include a strong desire to consume the narcotic, difficulties managing its use, giving drug use higher priority than some other exercises and obligations, increased intolerance, and occasionally a physical withdrawal state. It is important to note that substance misuse differs from addiction in that must be noted that substance abuse is distinct from addiction in that people with serious mental issues can quit or change their unhealthy behaviour, whereas gambling addiction could indeed stop that using prescription medications or materials even when they cause harm. Substance abuse refers to the risky or harmful use of addictive substances.
Title : Ectopically expressed olfactory receptors as an untapped family of drug targets and discovery of agonists and antagonists of OR51E1, an understudied G protein-coupled receptor
Vladlen Slepak, University of Miami Miller School of Medicine, United States
Title : Managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Analytical strategies for solid-state forms in drug development
Maria Cristina Gamberini, University of Modena e Reggio Emilia, Italy
Title : Understanding drug transport in plasma: The role of protein binding
Saad Tayyab, UCSI University, Malaysia
Title : Innovative development and delivery of biologics for chronic obstructive pulmonary disease
Yong Xiao Wang, Albany Medical College, United States
Title : Search for novel biomarkers and therapeutic targets for inflammatory disease
Madhav Bhatia, University of Otago, New Zealand
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model through de-sign-inspired biotech- & biopharma-driven applications and upgraded business mar-keting to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Design and evaluation of exo-itc: A bilayer fibrous system for controlled exosome delivery in dermatological applications
Luis Jesus Villarreal Gomez, FCITEC - Universidad AutĂłnoma de Baja California, Mexico
Title : Abuse-deterrent dosage form technique utilizing a fusion of innovative pharmaceuticals and ion exchange resin
Bhupendra Gopalbhai Prajapati, Parul University, India
Title : Macitentan/tadalafil combination– An additional value in pharmacotherapy of pulmonary arterial hypertension
Miroslav Radenkovic, University of Belgrade, Serbia